BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
375 results:

  • 1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA FOXD3-AS1 Contributes to Glioblastoma Progression Via Sponging miR-3918 to Upregulate ccnd1.
    Huang C; Shao T; Duan F; Li R; Luo M; Huang Q; Wang Y; Luo Z
    Turk Neurosurg; 2024; 34(2):224-234. PubMed ID: 38497174
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-throughput RNA sequencing identifies the miRNA expression profile, target genes, and molecular pathways contributing to growth of sporadic vestibular schwannomas.
    Litwiniuk-Kosmala M; Makuszewska M; Niemczyk K; Bartoszewicz R; Wojtas B; Gielniewski B
    Acta Neurochir (Wien); 2024 Feb; 166(1):71. PubMed ID: 38329606
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
    Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
    Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Regnase-2 inhibits glioblastoma cell proliferation.
    Sowinska W; Wawro M; Kochan J; Solecka A; Polak J; Kwinta B; Kasza A
    Sci Rep; 2024 Jan; 14(1):1574. PubMed ID: 38238463
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-cell neuroendocrine carcinoma.
    Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
    Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
    Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
    Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.
    Yuan J; Fu Y; Liu Y
    Medicine (Baltimore); 2023 Dec; 102(50):e36696. PubMed ID: 38115252
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small cell Lung Cancer Brain Metastases.
    Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis.
    Kapişkay DÜ; Ülgen ÖA; İnce Ü; Demirkesen C
    Turk J Med Sci; 2023 Aug; 53(4):924-933. PubMed ID: 38031947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Donati M; Grossmann P; Mansour B; Kazakov DV
    Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FLNA expression modulates pathological markers of pituitary neuroendocrine tumours.
    Toledo J; Perez PA; Zanetti M; Díaz-Torga G; Mukdsi JH; Gutierrez S
    J Endocrinol; 2024 Jan; 260(1):. PubMed ID: 37855268
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma.
    Qiao X; Chen Y; Wang Z; Peng N; Niu W; Hou S; Wu J; Ji Y; Niu C; Cheng C
    Cancer Gene Ther; 2023 Dec; 30(12):1702-1714. PubMed ID: 37845349
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Delayed time to radiation and overall survival in Merkel cell carcinoma.
    Ma KL; Sharon CE; Tortorello GN; Keele L; Lukens JN; Karakousis GC; Miura JT
    J Surg Oncol; 2023 Dec; 128(8):1385-1393. PubMed ID: 37622232
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies.
    Shimizu K; Kahramanian A; Jabbar MADA; Turna Demir F; Gokyer D; Uthamacumaran A; Rajan A; Saad MA; Gorham J; Wakimoto H; Martuza RL; Rabkin SD; Hasan T; Wakimoto H
    Cancer Lett; 2023 Sep; 572():216363. PubMed ID: 37619813
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.
    Kamimura K; Kamimura Y; Nakano T; Hasegawa T; Nakajo M; Yamada C; Akune K; Ejima F; Ayukawa T; Ito S; Nagano H; Takumi K; Nakajo M; Uchida H; Tabata K; Iwanaga T; Imai H; Feiweier T; Yoshiura T
    Cancer Imaging; 2023 Aug; 23(1):75. PubMed ID: 37553578
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.